+8.9%
GSK vs UTHR
+29.8%
-20.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | UTHR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | -0.4% | +0.5% | +0.2% |
| 7D | +0.5% | +4.9% | -4.4% | -0.4% |
| 30D | +9.4% | +9.2% | +0.3% | +7.8% |
| 3M | +1.6% | +15.9% | -14.4% | -1.0% |
| 6M | +1.3% | +2.0% | -0.7% | +1.7% |
| YTD | +6.0% | +21.8% | -15.8% | +2.5% |
| All | +8.9% | +29.8% | -20.8% | +2.7% |
Cumulative growth
Daily Returns
Daily percentage return beside UTHR.
Daily Out/Under-Performance
Portfolio return minus UTHR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UTHR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded UTHR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling